These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 23759289)

  • 1. The CERAD neuropsychological assessment battery total score detects and predicts Alzheimer disease dementia with high diagnostic accuracy.
    Wolfsgruber S; Jessen F; Wiese B; Stein J; Bickel H; Mösch E; Weyerer S; Werle J; Pentzek M; Fuchs A; Köhler M; Bachmann C; Riedel-Heller SG; Scherer M; Maier W; Wagner M;
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):1017-28. PubMed ID: 23759289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A total score for the CERAD neuropsychological battery.
    Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
    Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assessment of changes in cognitive functioning: age-, education-, and gender-specific reliable change indices for older adults tested on the CERAD-NP battery: results of the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe).
    Stein J; Luppa M; Luck T; Maier W; Wagner M; Daerr M; van den Bussche H; Zimmermann T; Köhler M; Bickel H; Mösch E; Weyerer S; Kaufeler T; Pentzek M; Wiese B; Wollny A; König HH; Riedel-Heller SG
    Am J Geriatr Psychiatry; 2012 Jan; 20(1):84-97. PubMed ID: 22183013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of Alzheimer's disease with a total score of the German CERAD.
    Ehrensperger MM; Berres M; Taylor KI; Monsch AU
    J Int Neuropsychol Soc; 2010 Sep; 16(5):910-20. PubMed ID: 20682088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies.
    Seo EH; Lee DY; Lee JH; Choo IH; Kim JW; Kim SG; Park SY; Shin JH; Do YJ; Yoon JC; Jhoo JH; Kim KW; Woo JI
    Am J Geriatr Psychiatry; 2010 Sep; 18(9):801-9. PubMed ID: 20220577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
    Aguirre-Acevedo DC; Jaimes-Barragán F; Henao E; Tirado V; Muñoz C; Reiman EM; Tariot PN; Langbaum JB; Lopera F
    Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H; Addneuromed Consortium
    J Alzheimers Dis; 2010; 22(4):1089-97. PubMed ID: 20930314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
    Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
    Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
    Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
    Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the Short Form of the Mini-Mental State Examination (MMSE) a better screening instrument for dementia in older primary care patients than the original MMSE? Results of the German study on ageing, cognition, and dementia in primary care patients (AgeCoDe).
    Stein J; Luppa M; Kaduszkiewicz H; Eisele M; Weyerer S; Werle J; Bickel H; Mösch E; Wiese B; Prokein J; Pentzek M; Fuchs A; König HH; Brettschneider C; Heser K; Wagner M; Riedel-Heller SG; Scherer M; Maier W
    Psychol Assess; 2015 Sep; 27(3):895-904. PubMed ID: 25822830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of digital clock drawing test in comparison with CERAD neuropsychological battery total score for discrimination of patients in the early course of Alzheimer's disease from healthy individuals.
    Müller S; Herde L; Preische O; Zeller A; Heymann P; Robens S; Elbing U; Laske C
    Sci Rep; 2019 Mar; 9(1):3543. PubMed ID: 30837580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of mini-mental status examination and revised hasegawa dementia scale for Alzheimer's disease.
    Kim KW; Lee DY; Jhoo JH; Youn JC; Suh YJ; Jun YH; Seo EH; Woo JI
    Dement Geriatr Cogn Disord; 2005; 19(5-6):324-30. PubMed ID: 15785033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CERAD (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychology Assessment Battery: 35 Years and Counting.
    Fillenbaum GG; Mohs R
    J Alzheimers Dis; 2023; 93(1):1-27. PubMed ID: 36938738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease?
    Camargo CHF; Bronzini A; Tolentino ES; Medyk C; Schultz-Pereira GL
    Arq Neuropsiquiatr; 2018 Mar; 76(3):145-149. PubMed ID: 29809231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validation of a short test (3MS-R) for detecting Alzheimer's disease].
    Alexopoulos P; Nadler K; Cramer B; Herpertz SC; Kurz A
    Fortschr Neurol Psychiatr; 2007 Dec; 75(12):728-36. PubMed ID: 17607642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
    Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
    Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery].
    Barth S; Schönknecht P; Pantel J; Schröder J
    Fortschr Neurol Psychiatr; 2005 Oct; 73(10):568-76. PubMed ID: 16217697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A normative study of total scores of the CERAD neuropsychological assessment battery in an educationally diverse elderly population.
    Han JY; Seo EH; Yi D; Sohn BK; Choe YM; Byun MS; Choi HJ; Kim SG; Park SY; Kim JW; Youn JC; Jhoo JH; Lee JH; Kim KW; Woo JI; Lee DY
    Int Psychogeriatr; 2014 Nov; 26(11):1897-904. PubMed ID: 25075438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.